Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 232 studies with search of: | "Everolimus" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Recruiting |
Randomized Phase I/II of RAD001 in Advanced Hepatocellular Carcinoma (HCC)
|
||||
2 | Recruiting |
Everolimus (RAD001) in Elderly Patients With Acute Myeloid Leukemia
|
||||
3 | Active, not recruiting |
Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex
|
||||
4 | Not yet recruiting |
RAD001 (Everolimus) For Advanced Renal Cell Carcinoma (RCC) Before Kidney Removal
|
||||
5 | Active, not recruiting |
Study of Everolimus in Patients With Recurrent Glioblastoma Multiforme
|
||||
6 | Recruiting |
Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients
|
||||
7 | Recruiting |
Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the Urothelium
|
||||
8 | Active, not recruiting |
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
|
||||
9 | Not yet recruiting |
Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)
|
||||
10 | Recruiting |
BEP Study Phase I (Bevacizumab, Everolimus, Panitumumab)
|
||||
11 | Recruiting |
RAD001 Salvage Monotherapy in Advanced Gastric Cancer (AGC) Who Failed Standard First-Line Treatment
|
||||
12 | Not yet recruiting |
RAD001 and Erlotinib in Patients With Neuroendocrine Tumors
|
||||
13 | Recruiting |
Post-Operative Radiation Therapy (IMRT) + RAD001 (Everolimus) + Cisplatin for Patients With Head and Neck Cancer
|
||||
14 | Active, not recruiting |
Erlotinib and RAD001 (Everolimus) in Patients With Previously Treated Advanced Pancreatic Cancer
|
||||
15 | Recruiting |
Avastin (Bevacizumab) and RAD001 (Everolimus) in Advanced Low or Intermediate Grade Neuroendocrine Carcinoma
|
||||
16 | Recruiting |
Efficacy and Safety of RAD001 in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)
|
||||
17 | Recruiting |
Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab in Adult Patients With Kidney Cancer
|
||||
18 | Recruiting |
A Phase III Trials Program Exploring the Integration of Bevacizumab, Everolimus (RAD001), and Lapatinib Into Current Neoadjuvant Chemotherapy Regimes for Primary Breast Cancer
|
||||
19 | Not yet recruiting |
Everolimus and Low Dose CNI Compared With MMF and Full CNI Dose in Heart Transplanted Patients: One Year Follow up
|
||||
20 | Recruiting |
CERTICOEUR: A Secondary Prevention Study of Skin Cancers in Heart Transplant Patients. Everolimus Versus Calcineurin Inhibitors Multicenter Trial
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |